QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-cargo-therapeutics-stock-is-gaining-today

CARGO shares rose after announcing a buyout deal with Concentra, including cash and potential future payouts tied to asset sales.

 jefferies-maintains-hold-on-cargo-therapeutics-raises-price-target-to-5

Jefferies analyst Michael Yee maintains Cargo Therapeutics (NASDAQ:CRGX) with a Hold and raises the price target from $3.7 t...

 concentra-biosciences-to-acquire-cargo-therapeutics-for-4379-cash-per-share-plus-contingent-value-right-deal-expected-to-close-august-2025

Concentra will acquire CARGO for $4.379 in cash per share of CARGO common stock, par value $0.001 per share ("CARGO Common ...

 cargo-therapeutics-suspends-crg-023--allogeneic-platform-initiates-90-workforce-reduction-anup-radhakrishnan-named-interim-ceo-to-explore-reverse-merger-3681m-cash-reserves-as-of-year-end-2024

- Development of CRG-023 and allogeneic platform suspended; further reduction in force (RIF) of approximately 90% to preserve c...

 truist-securities-downgrades-cargo-therapeutics-to-hold-lowers-price-target-to-7

Truist Securities analyst Asthika Goonewardene downgrades Cargo Therapeutics (NASDAQ:CRGX) from Buy to Hold and lowers the p...

 piper-sandler-downgrades-cargo-therapeutics-to-neutral-lowers-price-target-to-4

Piper Sandler analyst Biren Amin downgrades Cargo Therapeutics (NASDAQ:CRGX) from Overweight to Neutral and lowers the price...

 hc-wainwright--co-downgrades-cargo-therapeutics-to-neutral

HC Wainwright & Co. analyst Robert Burns downgrades Cargo Therapeutics (NASDAQ:CRGX) from Buy to Neutral.

 jp-morgan-downgrades-cargo-therapeutics-to-underweight

JP Morgan analyst Brian Cheng downgrades Cargo Therapeutics (NASDAQ:CRGX) from Overweight to Underweight.

 william-blair-downgrades-cargo-therapeutics-to-market-perform

William Blair analyst Sami Corwin downgrades Cargo Therapeutics (NASDAQ:CRGX) from Outperform to Market Perform.

 jefferies-downgrades-cargo-therapeutics-to-hold-lowers-price-target-to-3

Jefferies analyst Michael Yee downgrades Cargo Therapeutics (NASDAQ:CRGX) from Buy to Hold and lowers the price target from ...

 chardan-capital-downgrades-cargo-therapeutics-to-neutral

Chardan Capital analyst Geulah Livshits downgrades Cargo Therapeutics (NASDAQ:CRGX) from Buy to Neutral.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION